₹1 trillion market-cap stock club swells 27% to 119 in FY27
Among the new additions, Laurus Labs saw its market-cap rise 92 per cent to ₹1.03 trillion from ₹53,546 crore as of March 30, 2026
Profit by knowlytics
Among the new additions, Laurus Labs saw its market-cap rise 92 per cent to ₹1.03 trillion from ₹53,546 crore as of March 30, 2026
Sugar prices have surged notably, straining household budgets throughout India. This dramatic increase is attributed to lower domestic production coupled with heightened festive demand. Although government actions, such as permitting duty-free imports and implementing stock limits, have helped reduce mill gate prices, retail prices still soar as adjustments trickle through the supply chain. Looking ahead,…
Shares in fast-fashion online retail giant Shein lost around 10 per cent after it began trading on Hong Kong’s stock market Tuesday, after a long delay in the company’s plans to list its shares publicly. Shein raised about USD 1.7 billion, priced at 48.56 Hong Kong dollars (USD 6.19) a share, in its initial public…
Analysts attribute the decline in most jewellery stocks to profit booking by investors and an appeal by PM Modi to avoid buying gold if not needed.
Messi featured in six World Cups and seven Copa Americas before bringing the curtain down on his international career with Argentina
Tata Motors Ltd on Tuesday reported a 49 per cent growth in total commercial vehicle sales in August at 44,411 units as compared to 29,863 units in the same month last year. Domestic commercial vehicle sales were up 33 per cent at 36,619 units last month as compared to 27,481 units in August last year,…
A chartered accountant advises buyers to clarify the exact nature of the ownership arrangement before finalizing a purchase to avoid future legal and tax complications.
The Nifty Midcap and Smallcap indices outperformed the Nifty 50 index by 14 percentage points and 21 per centage points respectively at the peak levels in calendar year 2026, shows data.
Oil gains as renewed U.S.-Iran tensions raise risks to Hormuz oil flows
Sun Pharmaceutical Industries on Tuesday announced it has entered into an agreement with the US government to prioritise access to affordable medicines for American patients. As part of the agreement, signed during a ceremony at the White House, Mumbai-based Sun Pharma, India’s largest drugmaker, will extend ‘Most Favoured Nation’ (MFN) pricing to state Medicaid programmes,…